6505--Ultragenyx Pharmaceuticals, Inc. Effective: 08-01-2025 to 07-31-2030 36F79725D0172
Summary
AI-generated · Aug 27, 2025Ultragenyx Pharmaceuticals, Inc. has been awarded $2.5 million under a five-year term. The notice does not specify any unique requirements such as brand-name restrictions, certifications, or site visits.
Notice history
1-
Award Notice LATEST Posted Jul 22, 2025
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | MS1ZFMTA7JH7 | 6KD99 | NOVATO |
Contacts
VA Federal Supply Schedule (FSS) Service
Phone